Skip to content

Revitive Medic 2469MD

by Actegy, Ltd.

Revitive Medic 2469MD (2616) is a Class II device made by Actegy, Ltd., cleared under FDA 510(k) K152480 on 31 Mar 2016 and listed in FDA GUDID since 23 Apr 2018 (UDI-DI 00858058005085), active as of 22 Oct 2026.

Active United States. Also listed in GUDID (US).

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

510(k) K152480

FDA submission, from GUDID

Trust

Unverified

Source GUDID, synced 22 Oct 2026.

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing Number00858058005085 UDI-DI Date23 Apr 2018ListedStatusListed GUDID: in commercial distribution
United StatesFDA 510(k)SESE from GUDID Substantially Equivalent · Traditional NumberK152480 Date31 Mar 2016DecidedStatusActive

Official records

Across registries

2 registries list this device

  • FDA 510(k) K152480 decided 31 Mar 2016 Active
  • FDA GUDID UDI-DI 00858058005085 listed 23 Apr 2018 Listed

Timeline

2 dated events

  1. Cleared FDA 510(k) K152480
  2. Listed FDA GUDID 00858058005085

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

GUDID

Trade name
Revitive Medic
Generic name
Physical therapy transcutaneous electrical stimulation system, line-powered
Model / Ref / Catalog
2469MD, 2616
Primary DI / UDI-DI
00858058005085
510(k) Number
FDA product code
NUH, NGX
GMDN term
Physical therapy transcutaneous electrical stimulation system, line-powered
Device class
Class II
Regulation number
882.5890, 890.5850
GUDID distribution status
In Commercial Distribution

Similar devices

Other devices filed under FDA product code NUH (Stimulator, Nerve, Transcutaneous, Over-The-Counter).

Other devices from Actegy, Ltd.

See all devices from Actegy, Ltd. →

Properties

  • Over-the-counter
  • Serial number
  • Manufacturing date
Other properties (12, all answered No)